Khavandi
Healthcare
Pfizer
Australia
Biography
Kaivan Khavandiis studied in Royal College of Physicians (UK). & also studied in King's College London. His experiences includes with Medical Director (Inflammation & Immunology) At Pfizer, Employed from Jan 2017 – Present Employment Duration 8 months, Location is London, United Kingdom; Honorary Lecturer in Medicine at The University of Manchester Employed from Jan 2017 – Present Employment Duration 8 months; Co-Founder & Director at London et al Scientific Communications Ltd Employed from Dec 2012 – Dec 2016 Employment Duration 4 yrs. 1 months in the Location of London, United Kingdom; etc. His Publications are Abnormal remodelling of subcutaneous small arteries is associated with early diastolic impairment in metabolic syndrome Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels. Have we reached the limits for the treatment of diabetic nephropathy? Oral anticoagulants for Asian patients with atrial fibrillation the floods and ebbs in cholesterol lowering drug development: Prospects for the future Cardiovascular Protection in Type 2 Diabetes: Time to ADVANCE Management According to the Evidence Cardiovascular disease in chronic kidney disease: untying the Gordian knot etc.
Research Interest
"Medical Affairs Clinical development / R&D Medical Research External engagement & academic partnerships Scientific Communication Clinical Trials Publication Strategy Medical Education"
